Capricor Therapeutics Inc (CAPR.OQ)
Get access to over 18 million research reports from over 1,700 sources.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
- private equity
- third-party document and information retrieval
- and much, much more…
|59||2013||Independent Executive Chairman of the Board|
|51||2014||President, Chief Executive Officer, Director|
|44||2016||Chief Financial Officer, Principal Financial Officer|
|62||2013||Executive Vice President, General Counsel|
|29||2016||Principal Accounting Officer, Vice President - Finance|
- BRIEF-Capricor Therapeutics Announces Issuance Of Key U.S. Patent On Exosome Technology
- BRIEF-Capricor & California Institute For Regenerative Medicine Entered Into Amendment 3 To CIRM Notice Loan Award
- BRIEF-Capricor Therapeutics Says FDA Cleared IND Application For CAP-1002
- BRIEF-Capricor Therapeutics reports Q3 loss per share $0.12
- BRIEF-Capricor says results from Duchenne muscular dystrophy trial to be presented at AHA late-breaking session